Lullamin Uses, Dosage, Side Effects and more
Lullamin, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.
| Attribute | Details |
|---|---|
| Trade Name | Lullamin |
| Generic | Methapyrilene |
| Methapyrilene Other Names | Methapyrilene, Methypyrilene, Thenylpyramine |
| Type | |
| Formula | C14H19N3S |
| Weight | Average: 261.39 Monoisotopic: 261.129968798 |
| Groups | Withdrawn |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
